Latest filing published 05 Jan 2015 for Sonnet BioTherapeutics Holdings, Inc., €536.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Darren Howard Smith: trading record in brief
Darren Howard Smith is a declared insider of Sonnet BioTherapeutics Holdings, Inc., with filings sourced from SEC (Form 4). Between 7 October 2013 and 24 December 2014, the trades on record add up to 2 filings.
Every open-market trade on record is a purchase: 2 purchases worth €1,949, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2015 alone, the filings show 1 purchase and no sales.
Most recently, on 5 January 2015, the filings show an open-market purchase worth €536 in Sonnet BioTherapeutics Holdings, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Darren Howard Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 435 shares@ US$1.50Common StockSEC:0001144204-15-000492:0Canonical exit: 24 Mar 2015 (T+90)
- 376 shares@ US$5.10Common StockSEC:0001144204-13-054418:0Canonical exit: 5 Jan 2014 (T+90)
2 of 2 declarations